| Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|---|
 Filter
|
GSE214312
|
||||||||
| GSM6603936 |
Control (Mock) 1
|
SRA | 1 |
|
bomin Kim | Oct 02, 2022 | |||
| GSM6603937 |
Control (Mock) 2
|
SRA | 1 |
|
bomin Kim | Oct 02, 2022 | |||
| GSM6603938 |
Control (Mock) 3
|
SRA | 1 |
|
bomin Kim | Oct 02, 2022 | |||
| GSM6603939 |
EB2 treatment 1h 1
|
SRA | 1 |
|
bomin Kim | Oct 02, 2022 | |||
| GSM6603940 |
EB2 treatment 1h 2
|
SRA | 1 |
|
bomin Kim | Oct 02, 2022 | |||
| GSM6603941 |
EB2 treatment 1h 3
|
SRA | 1 |
|
bomin Kim | Oct 02, 2022 | |||
| GSM6603942 |
EB2 treatment 2h 1
|
SRA | 1 |
|
bomin Kim | Oct 02, 2022 | |||
| GSM6603943 |
EB2 treatment 2h 2
|
SRA | 1 |
|
bomin Kim | Oct 02, 2022 | |||
| GSM6603944 |
EB2 treatment 2h 3
|
SRA | 1 |
|
bomin Kim | Oct 02, 2022 | |||
| GSM6603945 |
EB2 treatment 4h 1
|
SRA | 1 |
|
bomin Kim | Oct 02, 2022 | |||
| GSM6603946 |
EB2 treatment 4h 2
|
SRA | 1 |
|
bomin Kim | Oct 02, 2022 | |||
| GSM6603947 |
EB2 treatment 4h 3
|
SRA | 1 |
|
bomin Kim | Oct 02, 2022 |
